drugset / Trial / NCT01870245

A Multiple Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 in Healthy Volunteers

NCT01870245 ↗

Phase 1 Terminated 4 enrolled Achaogen, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a randomized, double-blind, placebo-controlled, multiple-dose study, designed to assess the safety, tolerability, and pharmacokinetics (PK) of ACHN-975. This study will take place in the US at one clinical site.

Timeline

Start
2013-05
Primary completion
2013-06
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject ACHN-975 Small molecule — Intravenous

Indications

No indication recorded.